Yun Sijung, Urbanc B, Cruz L, Bitan G, Teplow D B, Stanley H E
Center for Polymer Studies, Department of Physics, Boston University, Boston, Massachusetts, USA.
Biophys J. 2007 Jun 1;92(11):4064-77. doi: 10.1529/biophysj.106.097766. Epub 2007 Feb 16.
Pathological folding and oligomer formation of the amyloid beta-protein (A beta) are widely perceived as central to Alzheimer's disease. Experimental approaches to study A beta self-assembly provide limited information because most relevant aggregates are quasi-stable and inhomogeneous. We apply a discrete molecular dynamics approach combined with a four-bead protein model to study oligomer formation of A beta. We address the differences between the two most common A beta alloforms, A beta 40 and A beta 42, which oligomerize differently in vitro. Our previous study showed that, despite simplifications, our discrete molecular dynamics approach accounts for the experimentally observed differences between A beta 40 and A beta 42 and yields structural predictions amenable to in vitro testing. Here we study how the presence of electrostatic interactions (EIs) between pairs of charged amino acids affects A beta 40 and A beta 42 oligomer formation. Our results indicate that EIs promote formation of larger oligomers in both A beta 40 and A beta 42. Both A beta 40 and A beta 42 display a peak at trimers/tetramers, but A beta 42 displays additional peaks at nonamers and tetradecamers. EIs thus shift the oligomer size distributions to larger oligomers. Nonetheless, the A beta 40 size distribution remains unimodal, whereas the A beta 42 distribution is trimodal, as observed experimentally. We show that structural differences between A beta 40 and A beta 42 that already appear in the monomer folding, are not affected by EIs. A beta 42 folded structure is characterized by a turn in the C-terminus that is not present in A beta 40. We show that the same C-terminal region is also responsible for the strongest intermolecular contacts in A beta 42 pentamers and larger oligomers. Our results suggest that this C-terminal region plays a key role in the formation of A beta 42 oligomers and the relative importance of this region increases in the presence of EIs. These results suggest that inhibitors targeting the C-terminal region of A beta 42 oligomers may be able to prevent oligomer formation or structurally modify the assemblies to reduce their toxicity.
淀粉样β蛋白(Aβ)的病理性折叠和寡聚体形成被广泛认为是阿尔茨海默病的核心。研究Aβ自组装的实验方法提供的信息有限,因为大多数相关聚集体是准稳定且不均匀的。我们应用离散分子动力学方法结合四珠蛋白模型来研究Aβ的寡聚体形成。我们研究了两种最常见的Aβ异构体Aβ40和Aβ42之间的差异,它们在体外的寡聚化方式不同。我们之前的研究表明,尽管进行了简化,但我们的离散分子动力学方法能够解释实验观察到的Aβ40和Aβ42之间的差异,并产生适合体外测试的结构预测。在这里,我们研究带电荷氨基酸对之间的静电相互作用(EIs)的存在如何影响Aβ40和Aβ42的寡聚体形成。我们的结果表明,EIs促进Aβ40和Aβ42中更大寡聚体的形成。Aβ40和Aβ42在三聚体/四聚体处均出现一个峰值,但Aβ42在九聚体和十四聚体处还出现额外的峰值。因此,EIs将寡聚体大小分布转移到更大的寡聚体。尽管如此,Aβ40的大小分布仍然是单峰的,而Aβ42的分布如实验观察到的那样是三峰的。我们表明,在单体折叠中就已出现的Aβ40和Aβ42之间的结构差异不受EIs影响。Aβ42的折叠结构的特征是C末端有一个转折,而Aβ40中不存在。我们表明,相同的C末端区域也是Aβ42五聚体和更大寡聚体中最强分子间接触的原因。我们的结果表明,这个C末端区域在Aβ42寡聚体的形成中起关键作用,并且在存在EIs的情况下该区域的相对重要性增加。这些结果表明,靶向Aβ42寡聚体C末端区域的抑制剂可能能够阻止寡聚体形成或在结构上修饰聚集体以降低其毒性。